FDA Adverse Event Malfunction Summary report: N

NEURON DELIVERY CATHETER 070

MDR report key: 2834569 · Received November 15, 2012

Report

Report Number
3005168196-2012-00383
Event Type
Malfunction
Date Received
November 15, 2012
Date of Event
October 16, 2012
Report Date
October 16, 2012
Manufacturer
PENUMBRA, INC.
Product Code
DQY
PMA / PMN Number
K082290
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ES
Reporter Occupation
BIOMEDICAL ENGINEER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS AVAILABLE FOR RETURN AND A FOLLOW-UP MDR WILL BE SUBMITTED UPON COMPLETION OF THE DEVICE INVESTIGATION.

Additional Manufacturer Narrative · 1

RESULTS: THE CATHETER IS BROKEN IN TWO PIECES. CONCLUSION: THE COMPLAINT IS CONFIRMED. BASED ON THE OBSERVATIONS DURING THE EVALUATION AND THE DESCRIPTION OF THE EVENT, THE CATHETER WAS LIKELY DAMAGED DURING REMOVAL FROM THE PACKAGE. THE TIP OF THE CATHETER DOES NOT APPEAR TO BE STUCK ON THE PACKAGING MANDREL. THERE IS NOTHING HOLDING THE CATHETER THAT WOULD HAVE KEPT IT FROM BEING REMOVED FROM THE PACKAGE OR CREATED RESISTANCE. DEPENDING ON HOW THE CATHETER WAS HANDLED DURING UNPACKAGING, IT IS POSSIBLE THAT THE USER ATTEMPTED TO PULL THE CATHETER FROM THE SHIPPING TUBE BEFORE THE PACKAGING MANDREL WAS REMOVED. BASED ON THE CRUSHED TIP OF THE CATHETER, IT IS ALSO POSSIBLE THAT THE USER ACCIDENTLY HELD THE CATHETER TIP IN PLACE WHILE PULLING ON THE HUB END DURING REMOVAL FROM THE SHIPPING TUBE. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Description of Event or Problem · 1

THE NURSE DESCRIBED THAT THE CATHETER WAS DAMAGED WHEN REMOVED FROM THE PACKAGE. THERE WAS SOME KIND OF STRING NOTED AS WELL AS RESISTANCE WHEN REMOVING THE CATHETER. THE CATHETER WAS DESCRIBED AS HAVING A CRUSHED TIP WITH THE INCORRECT TIP SHAPE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NEURON DELIVERY CATHETER 070 DQY DQY PENUMBRA, INC. F26599

Patients

Seq Age Sex Outcome Treatment
1 58 YR